That time I collabed with GE and Likeminds.
Likeminds was at a pivotal moment—their third round of funding—just after GE Healthcare stepped in to acquire their groundbreaking tech for the treatment of dopamine-related brain disorders, including Parkinsonian Syndromes, Lewy Body Dementia, addiction, depression, and ADHD.
Coded and launched a suite of digital platforms that made highly technical neurotech accessible to diverse stakeholders—clinicians, investors, and partners alike
Designed a scalable visual identity system and full set of marketing assets, bridging startup innovation with GE’s global brand standards
Led the creation of a funding pitch deck that secured investor buy-in by reframing complex neuroscience into compelling, opportunity-driven storytelling
Produced end-to-end video and multimedia campaigns, translating the tech’s impact into emotionally resonant narratives for use across web, pitch, and press
Authored high-clarity content—articles, explainer copy, and thought leadership—that established Likeminds as a category-defining voice in brain health innovation
It was incredible to connect with patients throughout this project.
*Due to NDA/client restrictions, not all deliverables are available for viewing
